Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus.
Type 2 diabetes mellitus (T2DM) and other metabolic disorders are often silent and go unnoticed in patients because of the lack of suitable prognostic and diagnostic markers. The current therapeutic regimens available for managing T2DM do not reverse diab..... Read More